[Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials]. (2017). Farmeconomia. Health Economics and Therapeutic Pathways, 18(1). https://doi.org/10.7175/fe.v18i1.1284